A Case Report of Chordoma Presenting as a Sphenoid Sinus Mass: A Diagnostic Challenge

Article ID: e010922208416 Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Introduction: Chordomas are midline tumors that arise from remnants of the primitive notochord, while the heterotopic rests are usually situated extradural within the bones of the axial skeleton. The tumor is locally aggressive with a high recurrence rate but rarely gives rise to metastasis.

Case Report: A 55-year-old female presented with complaints of headache and intermittent vomiting for six months and diminution of vision for the last four months. MRI, T1 weighted without contrast of the paranasal sinus, suggested sphenoid sinus malignancy or metastasis. The mass was excised and sent for histopathological examination. Based on the radiological findings, light microscopy, special stains, and immunohistochemistry, a final diagnosis of chordoma was rendered.

Results: The chordoma is a well-known entity at the skull base. Skull-based chordomas account for only 0.1-0.2% of all chordomas. The incidence rate of chordomas is 0.08 per 100,000, with a higher incidence rate of 0.1 in males than in females. However, chordoma presenting as a sphenoidal mass will create a diagnostic challenge for all otorhinolaryngologists and head and neck surgeons.

Conclusion: This case report aims to add this rare tumor to the differential diagnosis of neoplasms of the sphenoid sinus.

Keywords: Chordoma, physaliphorous, cells, sphenoidal, mass, female

[1]
Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH. Chordoma: The nonsarcoma primary bone tumor. Oncologist 2007; 12(11): 1344-50.
[http://dx.doi.org/10.1634/theoncologist.12-11-1344] [PMID: 18055855]
[2]
Leah P, Dower A, Vescovi C, Mulcahy M, Al Khawaja D. Clinical experience of intracranial chordoma – A systematic review and meta-analysis of the literature. J Clin Neurosci 2018; 53: 6-12.
[http://dx.doi.org/10.1016/j.jocn.2018.04.008] [PMID: 29724651]
[3]
Khawaja AM, Venkatraman A, Mirza M. Clival chordoma: Case report and review of recent developments in surgical and adjuvant treatments. Pol J Radiol 2017; 82: 670-5.
[http://dx.doi.org/10.12659/PJR.902008] [PMID: 29662593]
[4]
Barker FG, Linskey ME. History of the AANS/CNS joint section on tumors and preface to the 20th anniversary Journal of Neuro-Oncology special issue. J Neurooncol 2004; 69(1): 1-8.https://link.springer.com/article/10.1023/B:NEON.0000041868.00906.0a
[5]
Miptah HN, Badlishah SSF, Hashim H, Ramli AS. Clival chordoma in an adolescent: A perspective from primary care. Korean J Fam Med 2020; 41(6): 427-30.
[http://dx.doi.org/10.4082/kjfm.19.0004] [PMID: 32438537]
[6]
Barnes L. Diseases of the bones and joints. In: Barnes L, Verbin RS, Peel RL, Eds. Surgical pathology of the head and neck. New York: Marcel Dekker 2009; p. 1151.
[7]
Li X, Wang Y, Wang F, Li B, Sun S, Yang H. An unusual case of oropharyngeal chordoma. Medicine (Baltimore) 2017; 96(48): e8963.
[http://dx.doi.org/10.1097/MD.0000000000008963] [PMID: 29310398]
[8]
McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: Incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 2001; 12(1): 1-11.
[http://dx.doi.org/10.1023/A:1008947301735] [PMID: 11227920]
[9]
Riva P, Crosti F, Orzan F, et al. Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer 2003; 107(3): 493-7.
[http://dx.doi.org/10.1002/ijc.11421] [PMID: 14506752]
[10]
Kremenevski N, Schlaffer SM, Coras R, Kinfe TM, Graillon T, Buchfelder M. Skull base chordomas and chondrosarcomas. Neuroendocrinology 2020; 110(9-10): 836-47.
[http://dx.doi.org/10.1159/000509386] [PMID: 32541136]
[11]
Larson TC III, Houser OW, Laws ER Jr. Imaging of cranial chordomas. Mayo Clin Proc 1987; 62(10): 886-93.
[http://dx.doi.org/10.1016/S0025-6196(12)65043-5] [PMID: 3657305]
[12]
Erdem E, Angtuaco EC, Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics 2003; 23(4): 995-1009.
[http://dx.doi.org/10.1148/rg.234025176] [PMID: 12853676]
[13]
Forsyth PA, Cascino TL, Shaw EG, et al. Intracranial chordomas: A clinicopathological and prognostic study of 51 cases. J Neurosurg 1993; 78(5): 741-7.
[http://dx.doi.org/10.3171/jns.1993.78.5.0741] [PMID: 8468605]
[14]
O’Connell JX, Rosenberg AE, Renard LG, Liebsch NJ, Efird JT, Munzenrider JE. Base of skull chordoma. A correlative study of histologic and clinical features of 62 cases. Cancer 1994; 74(8): 2261-7.
[http://dx.doi.org/10.1002/1097-0142(19941015)74:8<2261:AID-CNCR2820740809>3.0.CO;2-0] [PMID: 7922977]
[15]
Silva Junior NA, Reis F, Miura LK, et al. Pituitary macroadenoma presenting as a nasal tumor: Case report. Sao Paulo Med J 2014; 132(6): 377-81.
[http://dx.doi.org/10.1590/1516-3180-2014-1326693] [PMID: 25351760]
[16]
Nishiguchi T, Mochizuki K, Ohsawa M, et al. Differentiating benign notochordal cell tumors from chordomas: Radiographic features on MRI, CT, and tomography. AJR Am J Roentgenol 2011; 196(3): 644-50.
[http://dx.doi.org/10.2214/AJR.10.4460] [PMID: 21343509]
[17]
Reis F, Schwingel R, Nascimento FBP. Central nervous system lymphoma: Iconographic essay. Radiol Bras 2013; 46: 110-6.
[http://dx.doi.org/10.1590/S0100-39842013000200016]